What is the latest price of Satclizumab (Anshiping) in 2024?

Satralizumab (Satralizumab) is an injection approved for the treatment of neuromyelitis optica spectrum disorder (NMOSD; an autoimmune disease of the nervous system that affects the nerves in the eyes and spinal cord). Satelizumab is a drug called an interleukin-6 (IL-6) receptor inhibitor, which works by blocking part of the immune system's activity in certain areas of the nervous system that can damage people with neuromyelitis optica spectrum disorder.

Satlizumab comes as a solution (liquid) injected subcutaneously (under the skin), usually every 2 weeks for the first 3 doses, then every 4 weeks for as long as your doctor advises you to take treatment. The doctor may decide that the patient or caregiver can get the injection at home. 30 minutes before you are ready to inject the medication, remove the carton containing the medication from the refrigerator and remove the syringe. Patients can receive satlizumab injection into the front and middle thighs or anywhere on the abdomen, except for the belly button and a 2-inch area around it. Do not inject this medication into tender, bruised, damaged, or scarred skin. Change (rotate) the injection site with each injection. Choose a different site each time you inject the medication.

The original drug satlizumab has been launched in China, sold under the brand name Anshiping, and is included in medical insurance. Only patients who meet the indications can be reimbursed. The specification is120mg (1ml) per box The price may be more than RMB 10,000, which is still relatively expensive; the price of each box of the original drug Saterizumab sold overseas is more than $10,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drug sold domestically and abroad are basically the same. There are currently no generic versions of satlizumab available on the market.